Exscientia

develops an AI-based platform that enables to design and develop small molecule drugs...
Read more
Exscientia Founder & CEO: Andrew Hopkins

Founder & CEO

Andrew Hopkins

CEO Approval Rating

81/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
100-250
Agree?
Funding
$372.9M
Acquisitions
1

Exscientia Competitors

1Atomwise
2Cyclica
3Schrodinger
4Numerate
5twoXAR
6Certara
7CCG
8Recursion
9MolySym
10Wavefunction

Trending Companies